Genmab A/S
BISPECIFIC ANTIBODIES AGAINST HER2
Last updated:
Abstract:
Bispecific antibodies which comprise antigen-binding regions binding to two different epitopes of human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods of preparing and using the antibodies are also disclosed.
Status:
Application
Type:
Utility
Filling date:
14 Jan 2021
Issue date:
21 Oct 2021